Catalyst Advisors Adds New Partner

Catalyst Advisors Adds Partner Arnaldo De Lisio London

October 12, 2017 – Persistent talent shortages and the need to develop and retain employees with critical business and technology skill-sets will continue to challenge global life sciences companies for the foreseeable future, according to Deloitte’s global sector outlook on life sciences.  Navigating this new world of work requires a dramatic change in strategies for leadership, talent and human resources.

What’s more, the global life sciences sector in the midst of a turbulent transformation, making the need for innovative leaders more important than ever. So it is that search firms are staffing up to meet the demand. In the latest instance, Catalyst Advisors, a board and C-level recruiting firm focused on the biopharma industry, has expanded with the addition of Arnaldo De Lisio as a partner. He will be based in London along with Simon Bartholomew, who opened that office in 2014.

Respected Leader

“Arnaldo is a respected counselor to the boards and CEOs of European life sciences enterprises, and we are very pleased to have him as part of Catalyst Advisors,” said founder John Archer. “Having firmly established our position in the North American market, we are now making a concerted effort to expand our global footprint. Adding Arnaldo’s market knowledge, networks and experience is the first step in that strategy.”

Tapping Outside Talent for Life Science and Healthcare
For these top 50 executive recruiters working in the life science and healthcare sectors, the last decade has been one of transformation. Pressure on pricing, regulatory changes, emerging innovations, growth, and an uncertain political environment have all helped shape a new field of play.

Top 50 Ranking

Mr. De Lisio was previously with Coulter Partners, where he was a managing partner. During his 12 years there, he conducted board, CEO and other C-level recruitment engagements for biopharma, traditional pharma, med tech and venture capital firms in both Europe and North America. He has deep experience working with clients in highly innovative areas of medicine, including immuno-oncology, oncology and rare diseases. He also played a key role on the executive team that developed the firm’s strategy and led its growth.

Prior to Coulter Partners, Mr. De Lisio was a start-up entrepreneur in Italy and a management consultant at Simon-Kucher & Partners in Germany, where he advised biopharma and pharmaceutical companies on pricing and reimbursement strategies.

“Boards and investors know that top-tier leadership teams are essential in today’s complex and fast-moving life sciences market,” Mr. De Lisio said. “Catalyst Advisors has become a go-to resource for leadership at a time when the competition for talent is relentless, and I’m excited to be a part of the team.”

Evolving Dynamics of Recruiting In Life Sciences
As the life sciences sector evolves, this specialized area of executive recruiting is changing as well. For Adam Bloom, president of The Stevenson Group, his expanding role as talent evaluator has elevated in importance due to shifting market forces.

Life Sciences Recruiters

With offices in New York, London and Los Angeles, Catalyst Advisors is focused on finding C-suite leaders and board directors for biopharma companies ranging from established, publicly-held enterprises to start-ups backed by leading venture funds. Publicly-held clients include Acceleron Pharma, AveXis, BioMarin, Gilead Sciences, Intercept Pharmaceuticals, Ovid Therapeutics, Regeneron and Shire, among others.

Contributed by Scott A. Scanlon, Editor-in-Chief; Dale M. Zupsansky, Managing Editor; Stephen Sawicki, Managing Editor; and Will Schatz, Managing Editor – Hunt Scanlon Media

Share This Article


Notify of
Inline Feedbacks
View all comments